Publications by authors named "Markolf Hanefeld"

100Publications

Rationale for Timely Insulin Therapy in Type 2 Diabetes Within the Framework of Individualised Treatment: 2020 Update.

Diabetes Ther 2020 Aug 20;11(8):1645-1666. Epub 2020 Jun 20.

Division of Endocrinology and Diabetology, Department of Medicine II, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s13300-020-00855-5DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7376805PMC
August 2020

Remission of type 2 diabetes and pleiotropic effects of long-term testosterone treatment for "late-onset" hypogonadism: A case report.

SAGE Open Med Case Rep 2019 16;7:2050313X18823454. Epub 2019 Jan 16.

Studienzentrum Metabolisch-Vaskuläre Medizin, GWT-TUD GmbH, Dresden, Germany.

View Article

Download full-text PDF

Source
http://journals.sagepub.com/doi/10.1177/2050313X18823454
Publisher Site
http://dx.doi.org/10.1177/2050313X18823454DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6349975PMC
January 2019

Sudomotor Testing of Diabetes Polyneuropathy.

Front Neurol 2018 26;9:803. Epub 2018 Sep 26.

Autonomic and Neuroendocrinological Laboratory Dresden, Center of Clinical Neuroscience, University Hospital Carl Gustav Carus, Dresden, Germany.

View Article

Download full-text PDF

Source
https://www.frontiersin.org/article/10.3389/fneur.2018.00803
Publisher Site
http://dx.doi.org/10.3389/fneur.2018.00803DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6168653PMC
September 2018

The anorexigenic peptide neurotensin relates to insulin sensitivity in obese patients after BPD or RYGB metabolic surgery.

Int J Obes (Lond) 2018 12 24;42(12):2057-2061. Epub 2018 May 24.

Section of Metabolic and Vascular Medicine, Medical Clinic III, University Hospital Carl Gustav Carus, Dresden, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41366-018-0084-3DOI Listing
December 2018

A review of glucagon-like peptide-1 receptor agonists and their effects on lowering postprandial plasma glucose and cardiovascular outcomes in the treatment of type 2 diabetes mellitus.

Diabetes Obes Metab 2017 12 11;19(12):1645-1654. Epub 2017 Jul 11.

Study Centre "Professor Hanefeld", GWT-Technical University Dresden, Dresden, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/dom.12998DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5697665PMC
December 2017

Efficacy and safety of lixisenatide in patients with type 2 diabetes and renal impairment.

Diabetes Obes Metab 2017 11 7;19(11):1594-1601. Epub 2017 Jun 7.

Internal Medicine Department, University Regional Hospital, Malaga, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/dom.12986DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5655920PMC
November 2017

Metabolic Vascular Syndrome: New Insights into a Multidimensional Network of Risk Factors and Diseases.

Visc Med 2016 Oct 7;32(5):319-326. Epub 2016 Oct 7.

GWT-TUD GmbH, Dresden Technical University, Dresden, Germany; Medical Clinic III, University Hospital Carl Gustav Carus, Dresden, Dresden, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000450866DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5122997PMC
October 2016

Comment on Ferrannini et al. CV Protection in the EMPA-REG OUTCOME Trial: A "Thrifty Substrate" Hypothesis. Diabetes Care 2016;39:1108-1114.

Diabetes Care 2016 12;39(12):e224-e225

Clinical Study Centre Professor Hanefeld, GWT TU-Dresden GmbH, Dresden, Germany

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2337/dc16-1588DOI Listing
December 2016

Individualized, patient-centered use of lixisenatide for the treatment of type 2 diabetes mellitus.

Expert Opin Drug Metab Toxicol 2017 Mar 3;13(3):311-321. Epub 2016 Nov 3.

c Laboratory of Human Nutrition and Atherosclerosis, Institute of Clinical Research , University of Montpellier I , Montpellier , France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/17425255.2017.1251579DOI Listing
March 2017

Hypoglycemia and Cardiovascular Risk: Is There a Major Link?

Diabetes Care 2016 Aug;39 Suppl 2:S205-9

Study Centre Professor Hanefeld, GWT-TU Dresden GmbH, Dresden, Germany Medical Clinic III, Universitätsklinikum "Carl Gustav Carus," Dresden, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2337/dcS15-3014DOI Listing
August 2016

Determinants of mortality in patients with type 2 diabetes: a review.

Rev Endocr Metab Disord 2016 03;17(1):129-37

Health Sciences/Public Health, Faculty of Medicine, TUD, Fetscherstraße 74, D-01307, Dresden, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11154-016-9349-0DOI Listing
March 2016

The metabolic vascular syndrome - guide to an individualized treatment.

Rev Endocr Metab Disord 2016 03;17(1):5-17

GWT-TU Dresden GmbH, Fiedlerstr. 34, 01307, Dresden, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11154-016-9345-4DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4882364PMC
March 2016

Hypoglycemia and Cardiovascular Disease: Lessons from Outcome Studies.

Curr Diab Rep 2015 Dec;15(12):117

Study Center Professor Hanefeld, GWT TU-Dresden GmbH, Fiedlerstrasse 34, 01307, Dresden, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11892-015-0678-2DOI Listing
December 2015

Risk of and risk factors for hypoglycemia and associated arrhythmias in patients with type 2 diabetes and cardiovascular disease: a cohort study under real-world conditions.

Acta Diabetol 2015 Oct 10;52(5):889-95. Epub 2015 Mar 10.

Studienzentrum Professor Hanefeld, GWT-TU Dresden GmbH, Fiedlerstr. 34, 01307, Dresden, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00592-015-0727-yDOI Listing
October 2015

Lixisenatide treatment for older patients with type 2 diabetes mellitus uncontrolled on oral antidiabetics: meta-analysis of five randomized controlled trials.

Adv Ther 2014 Aug 21;31(8):861-72. Epub 2014 Aug 21.

GWT-TUD, Study Centre Prof. Hanefeld, Dresden Technical University, Fiedlerstr. 34, 01307, Dresden, Germany,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12325-014-0146-4DOI Listing
August 2014

Self-monitoring of blood glucose: a prerequisite for diabetes management in outcome trials.

J Diabetes Sci Technol 2014 May 2;8(3):609-14. Epub 2014 Apr 2.

Institute of Clinical Research, University Montpellier I, Laboratoire de Nutrition Humaine, Institut Universitaire de Recherche Clinique, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1932296814528134DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4455440PMC
May 2014

Differences in Glycemic Variability Between Normoglycemic and Prediabetic Subjects.

J Diabetes Sci Technol 2014 Mar 2;8(2):286-290. Epub 2014 Mar 2.

Study Centre Prof. Hanefeld, GWT-TUD GmbH, Dresden, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1932296814522739DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4455406PMC
March 2014

Predictors of response to early basal insulin treatment in patients with type 2 diabetes--the EARLY experience.

Diabetes Technol Ther 2014 Apr 14;16(4):241-6. Epub 2013 Nov 14.

1 Study Centre Professor Hanefeld, Company for the Transfer of Knowledge and Technology of the Dresden University of Technology , Dresden, Germany .

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/dia.2013.0246DOI Listing
April 2014

Cardiac implications of hypoglycaemia in patients with diabetes - a systematic review.

Cardiovasc Diabetol 2013 Sep 21;12:135. Epub 2013 Sep 21.

Study Centre Professor Hanefeld, GWT, TU Dresden, Dresden, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1475-2840-12-135DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3849493PMC
September 2013

The role of co-morbidity in the selection of antidiabetic pharmacotherapy in type-2 diabetes.

Cardiovasc Diabetol 2013 Apr 10;12:62. Epub 2013 Apr 10.

Herz- und Diabeteszentrum Nordrhein-Westfalen in Bad Oeynhausen, Universitätsklinik der Ruhr Universität, Bochum, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1475-2840-12-62DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3664601PMC
April 2013

Insulin use early in the course of type 2 diabetes mellitus: the ORIGIN trial.

Curr Diab Rep 2013 Jun;13(3):342-9

GWT-TUD mbH, Study Center Professor Hanefeld, Fiedlerstr. 34, 01307 Dresden, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11892-013-0366-zDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3647081PMC
June 2013

Association of sulphonylurea treatment with all-cause and cardiovascular mortality: a systematic review and meta-analysis of observational studies.

Diab Vasc Dis Res 2013 Jul 4;10(4):302-14. Epub 2013 Jan 4.

Institute for Clinical Research and Development (IKFE), Mainz, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1479164112465442DOI Listing
July 2013

The metabolic syndrome and cardiovascular disease - an ongoing tsunami.

Pediatr Endocrinol Diabetes Metab 2013 ;20(1):5-11

View Article

Download full-text PDF

Source
September 2017

Should antidiabetic treatment of type 2 diabetes in patients with heart failure differ from that in patients without?

Eur J Heart Fail 2012 Dec 13;14(12):1389-400. Epub 2012 Sep 13.

Institut für Herzinfarktforschung Ludwigshafen an der Universität Heidelberg, Bremser Strasse 79, D-67063 Ludwigshafen, Germany.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1093/eurjhf/hfs136
Publisher Site
http://dx.doi.org/10.1093/eurjhf/hfs136DOI Listing
December 2012

Acarbose revisited for efficacy, safety and cardiovascular benefits: a key role for controlling glycemic variability.

Authors:
Markolf Hanefeld

Expert Rev Endocrinol Metab 2012 Jul;7(4):395-405

a Center for Clinical Studies, GWT - Technical University Dresden, Fiedlerstrasse 34, 01307 Dresden, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/eem.12.35DOI Listing
July 2012

Conversion of IGT to type 2 diabetes mellitus is associated with incident cases of hypertension: a post-hoc analysis of the STOP-NIDDM trial.

J Hypertens 2012 Jul;30(7):1440-3

Center for Clinical Studies, Technical University Dresden, Dresden, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/HJH.0b013e328354663cDOI Listing
July 2012

Urinary tract infection in patients with diabetes mellitus.

Clin Nephrol 2012 Jan;77(1):40-8

Department of Internal Medicine, Sophien- und Hufeland-Klinikum Weimar, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5414/cn107216DOI Listing
January 2012

Review of approved pioglitazone combinations for type 2 diabetes.

Expert Opin Pharmacother 2011 Jul 4;12(10):1571-84. Epub 2011 Jun 4.

IKFE - Institute for Clinical Research and Development, Parcusstr. 8, D-5116 Mainz, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/14656566.2011.567266DOI Listing
July 2011

Is hyperglycemia a cardiovascular risk factor?

Diabetes Care 2011 May;34 Suppl 2:S128-31

Center for Clinical Studies, Endocrinology and Metabolic Research, GWT, Technical University Dresden, Dresden, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2337/dc11-s207DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3632149PMC
May 2011

[Multimodal therapy of dyslipidemia].

Clin Res Cardiol Suppl 2011 May;6:10-6

Zentrum für klinische Studien, Fiedlerstraße 34, Dresden, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11789-011-0031-5DOI Listing
May 2011

Dapagliflozin, an SGLT2 inhibitor, for diabetes.

Lancet 2010 Jun;375(9733):2196-8

Centre for Clinical Studies, Gesellschaft für Wissens-und Technologietransfer, Technical University Dresden, 01307 Dresden, Germany.

View Article

Download full-text PDF

Source
http://care.diabetesjournals.org/content/diacare/35/7/1473.f
Web Search
http://www.thelancet.com/pdfs/journals/lancet/PIIS0140-6736(
Web Search
http://linkinghub.elsevier.com/retrieve/pii/S014067361060749
Publisher Site
http://dx.doi.org/10.1016/S0140-6736(10)60749-0DOI Listing
June 2010

Metabolic syndrome and its single traits as risk factors for diabetes in people with impaired glucose tolerance: the STOP-NIDDM trial.

Diab Vasc Dis Res 2009 Jan;6(1):32-7

Centre for Clinical Studies, GWT-TUD GmbH, Fiedlerstr. 34, 01307 Dresden, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3132/dvdr.2009.006DOI Listing
January 2009

The Finnish Diabetes Risk Score is associated with insulin resistance and progression towards type 2 diabetes.

J Clin Endocrinol Metab 2009 Mar 23;94(3):920-6. Epub 2008 Dec 23.

Medical Faculty Carl-Gustav-Carus of Technical University Dresden, Medical Clinic III, Building 10, Room 108, Fetscherstrasse 74, 01309 Dresden, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1210/jc.2007-2427DOI Listing
March 2009

Effect of acarbose on vascular disease in patients with abnormal glucose tolerance.

Cardiovasc Drugs Ther 2008 Jun 29;22(3):225-31. Epub 2008 Feb 29.

Center for Clinical Studies, GWT-TUD GmbH, Dresden, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10557-008-6091-1DOI Listing
June 2008

Acarbose: oral anti-diabetes drug with additional cardiovascular benefits.

Expert Rev Cardiovasc Ther 2008 Feb;6(2):153-63

Centre for Clinical Studies, Dresden, Fiedlerstrasse 34, 01307 Dresden, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/14779072.6.2.153DOI Listing
February 2008

Is rosiglitazone associated with increased risk for cardiovascular events?

Authors:
Markolf Hanefeld

Nat Clin Pract Cardiovasc Med 2007 Dec 9;4(12):648-9. Epub 2007 Oct 9.

Centre for Clinical Studies at the Technical University in Dresden, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ncpcardio1030DOI Listing
December 2007

Cardiovascular benefits and safety profile of acarbose therapy in prediabetes and established type 2 diabetes.

Authors:
Markolf Hanefeld

Cardiovasc Diabetol 2007 Aug 15;6:20. Epub 2007 Aug 15.

Zentrum für Klinische Studien, GWT, Technische Universität Dresden, Dresden, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1475-2840-6-20DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2040135PMC
August 2007

Once-daily sitagliptin, a dipeptidyl peptidase-4 inhibitor, for the treatment of patients with type 2 diabetes.

Curr Med Res Opin 2007 Jun 30;23(6):1329-39. Epub 2007 Apr 30.

GWT-Technical University, Dresden, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1185/030079907X188152DOI Listing
June 2007

Rosiglitazone evaluated for cardiovascular outcomes--an interim analysis.

N Engl J Med 2007 Jul 5;357(1):28-38. Epub 2007 Jun 5.

Newcastle Diabetes Centre and Newcastle University, Newcastle upon Tyne, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa073394DOI Listing
July 2007

Relationship between diurnal blood pressure variation and diurnal blood glucose levels in type 2 diabetic patients.

Am J Hypertens 2007 May;20(5):541-5

Department of Medicine, Nephrology, University Hospital, Dresden, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.amjhyper.2006.10.010DOI Listing
May 2007

Glucagon as a determinant of fibrinolytic activity in men with different stages of glucose tolerance: impact of glucagon on fibrinolysis.

Blood Coagul Fibrinolysis 2007 Jun;18(4):327-34

Centre for Clinical Studies-Metabolism and Endocrinology, GWT TU Dresden, Technical University Dresden, Fiedlerstrasse 34, D-01307 Dresden, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MBC.0b013e32809cc90bDOI Listing
June 2007

Impact of the individual components of the metabolic syndrome and their different combinations on the prevalence of atherosclerotic vascular disease in type 2 diabetes: the Diabetes in Germany (DIG) study.

Cardiovasc Diabetol 2007 Apr 26;6:13. Epub 2007 Apr 26.

Center for Clinical Studies-Metabolism and Endocrinology, Science and Technology Transfer, TU Dresden, Dresden, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1475-2840-6-13DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1871572PMC
April 2007

A one-year study comparing the efficacy and safety of rosiglitazone and glibenclamide in the treatment of type 2 diabetes.

Nutr Metab Cardiovasc Dis 2007 Jan 20;17(1):13-23. Epub 2006 Mar 20.

Centre for Clinical Studies, GWT Technical University, Dresden, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.numecd.2005.12.003DOI Listing
January 2007

Elevated fasting glucose levels predicts IGT and diabetes also in middle-age subjects.

Diabetes Res Clin Pract 2007 Jul 7;77(1):148-50. Epub 2006 Nov 7.

Department of Endocrinopathies and Metabolic Diseases, Medical Faculty Carl-Gustav-Carus of the Technical University Dresden, Fetscherstrasse 74, Dresden, Germany.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S016882270600457
Publisher Site
http://dx.doi.org/10.1016/j.diabres.2006.10.001DOI Listing
July 2007

Postprandial hyperglycaemia and cardiovascular complications of diabetes: an update.

Nutr Metab Cardiovasc Dis 2006 Oct 24;16(7):453-6. Epub 2006 Aug 24.

Clinical Science Research Institute, Clinical Science Building, Warwick Medical School, University of Warwick, Coventry, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.numecd.2006.05.006DOI Listing
October 2006

Hypoadiponectinemia is associated with progression toward type 2 diabetes and genetic variation in the ADIPOQ gene promoter.

Diabetes Care 2006 Jul;29(7):1645-50

Department of Endocrinopathies and Metabolic Diseases, Medical Faculty Carl-Gustav-Carus of the Technical University Dresden, Medical Clinic III, Building 46, Room 10, Fetscherstrasse 74, 01309, Dresden, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2337/dc05-2123DOI Listing
July 2006

[Metabolic syndrome: "common soil" for diabetes and atherosclerosis. Novel approaches to an integrated therapy].

Herz 2006 May;31(3):246-54; quiz 255

Zentrum für Klinische Studien der GWT-TUD GmbH, Fiedlerstrasse 74, 01307, Dresden, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00059-006-2798-6DOI Listing
May 2006

Postprandial glucose regulation: new data and new implications.

Clin Ther 2005 ;27 Suppl B:S42-56

St. Michael's Hospital, University of Toronto, Toronto, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clinthera.2005.11.020DOI Listing
March 2006

Prandial hyperglycemia: is it important to track and treat?

Curr Diab Rep 2005 Oct;5(5):333-9

Centre of Clinical Studies, GWT-Technical University Dresden, Fiedlerstrasse, Dresden 34 01307, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11892-005-0090-4DOI Listing
October 2005

Impact of glucagon response on postprandial hyperglycemia in men with impaired glucose tolerance and type 2 diabetes mellitus.

Metabolism 2005 Sep;54(9):1168-73

Centre for Clinical Studies-Metabolism and Endocrinology, Science and Technology Transfer, Technical University, D-01307 Dresden, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.metabol.2005.03.024DOI Listing
September 2005